InnoCare Optoelectronics Corp.

As of June 30, 2026, InnoCare Optoelectronics Corp. carries a market capitalization of 13.85B, placing it among publicly traded companies globally. Its enterprise value stands at 13.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

InnoCare Optoelectronics Corp.'s next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, InnoCare Optoelectronics Corp. has 41.60M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, InnoCare Optoelectronics Corp. maintains a current ratio of 2.10, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, InnoCare Optoelectronics Corp. recorded 52.59M in income tax expense.

As of the close on October 22, 2026, InnoCare Optoelectronics Corp.'s stock has gained approximately 244.07% over the past 52 weeks. The 50-day moving average sits at 229.28, while the 200-day moving average is 217.32.

As of June 30, 2026, InnoCare Optoelectronics Corp. holds 867.46M in cash and equivalents against 108.35M in total debt, resulting in a net debt position of -807.46M. Total book value stands at 1.56B, with working capital of 1.41B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.